UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI EAFE ETF
IEFA
|
+$4.47B |
| 2 |
Vanguard Russell 1000 Growth ETF
VONG
|
+$2.93B |
| 3 |
Vanguard Russell 1000 Value ETF
VONV
|
+$2.75B |
| 4 |
iShares Broad USD Investment Grade Corporate Bond ETF
USIG
|
+$2.69B |
| 5 |
Vanguard Morningstar Mid-Cap ETF
VO
|
+$2.33B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UBS Group
UBS
|
+$1.44B |
| 2 |
Micron Technology
MU
|
+$919M |
| 3 |
CYBR
CyberArk
CYBR
|
+$851M |
| 4 |
Honeywell
HON
|
+$606M |
| 5 |
Merck
MRK
|
+$605M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 39.16% |
| 2 | Technology | 16.96% |
| 3 | Financials | 8.4% |
| 4 | Industrials | 7.09% |
| 5 | Healthcare | 6.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
6201
Woori Financial
WF
$18.5B
| $398K | ﹤0.01% |
5,969
+2,548
| +74% | +$172K |
2014 Q4
45 quarters
|
|
6202
CS Disco
LAW
$271M
| $396K | ﹤0.01% |
103,587
+88,130
| +570% | +$436K |
2021 Q4
17 quarters
|
|
6203
Envela
ELA
$316M
| $395K | ﹤0.01% |
23,709
-216
| -0.9% | -$2.97K |
2019 Q4
25 quarters
|
|
6204
First Trust Dividend Strength ETF
FTDS
$37.3M
| $395K | ﹤0.01% |
6,547
| – | – |
2015 Q1
44 quarters
|
|
|
OMDA
6205
Omada Health Inc
OMDA
$1.25B
| $393K | ﹤0.01% |
31,244
-28,985
| -48% | -$400K |
2025 Q2
3 quarters
|
|
6206
CALL
Ally Financial
ALLY
$11.5B
| $392K | ﹤0.01% |
+10,000
| New | +$412K |
2026 Q1
0 quarters
|
|
|
JFLX
6207
JPMorgan Flexible Debt ETF
JFLX
$1.51B
| $391K | ﹤0.01% |
7,877
-23,732
| -75% | -$1.19M |
2025 Q3
2 quarters
|
|
6208
Alto Neuroscience
ANRO
$973M
| $388K | ﹤0.01% |
17,250
-1,239
| -7% | -$23K |
2024 Q1
8 quarters
|
|
6209
CALL
Global Payments
GPN
$20.7B
| $387K | ﹤0.01% |
5,750
+3,250
| +130% | +$240K |
2024 Q2
7 quarters
|
|
6210
UNIFI
UFI
$122M
| $385K | ﹤0.01% |
107,746
-3,572
| -3% | -$13.8K |
2014 Q4
45 quarters
|
|
|
LPRO
6211
DELISTED
Open Lending Corp
LPRO
| $384K | ﹤0.01% |
307,398
+138,198
| +82% | +$218K |
2022 Q2
15 quarters
|
|
6212
Inhibikase Therapeutics
IKT
$279M
| $383K | ﹤0.01% |
228,151
+133,606
| +141% | +$237K |
2024 Q3
6 quarters
|
|
6213
ALPS Clean Energy ETF
ACES
$102M
| $383K | ﹤0.01% |
11,435
-730
| -6% | -$25.2K |
2021 Q3
18 quarters
|
|
6214
Blue Ridge Bankshares
BRBS
$352M
| $383K | ﹤0.01% |
91,124
-90,772
| -50% | -$380K |
2022 Q4
13 quarters
|
|
6215
Falcon's Beyond
FBYD
$415M
| $383K | ﹤0.01% |
27,142
-3,389
| -11% | -$24.5K |
2024 Q2
7 quarters
|
|
6216
Invesco Bond Fund
VBF
$162M
| $383K | ﹤0.01% |
25,500
-26,330
| -51% | -$402K |
2014 Q4
45 quarters
|
|
6217
1-800-Flowers.com
FLWS
$164M
| $381K | ﹤0.01% |
125,413
-57,617
| -31% | -$216K |
2014 Q4
45 quarters
|
|
|
AVBH
6218
Avidbank Holdings
AVBH
$343M
| $380K | ﹤0.01% |
13,346
-14,748
| -52% | -$416K |
2025 Q3
2 quarters
|
|
6219
PUT
Banco Bradesco
BBD
$38.7B
| $380K | ﹤0.01% |
+104,000
| New | +$394K |
2026 Q1
0 quarters
|
|
|
EONR
6220
EON Resources
EONR
$27.2M
| $379K | ﹤0.01% |
456,980
+154,429
| +51% | +$91.3K |
2024 Q1
8 quarters
|
|
|
MRCC
6221
DELISTED
Monroe Capital Corp
MRCC
| $379K | ﹤0.01% |
82,452
+13,728
| +20% | +$79.3K |
2014 Q4
45 quarters
|
|
6222
CALL
Summit Therapeutics
SMMT
$13.4B
| $379K | ﹤0.01% |
+20,000
| New | +$323K |
2026 Q1
0 quarters
|
|
6223
Douglas Elliman
DOUG
$141M
| $379K | ﹤0.01% |
231,187
+61,804
| +36% | +$143K |
2021 Q4
17 quarters
|
|
|
ANPA
6224
Rich Sparkle Holdings
ANPA
$29.8M
| $379K | ﹤0.01% |
44,647
+44,516
| +33,982% | +$1.75M |
2025 Q3
2 quarters
|
|
6225
Ituran Location and Control
ITRN
$1.04B
| $377K | ﹤0.01% |
7,702
-4,350
| -36% | -$205K |
2014 Q4
45 quarters
|
|
Similar funds
UBS Group's Q1 2026 Portfolio in Review
As of Q1 2026, UBS Group held 11,786 positions worth $666B, up 8% from $617B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
UBS Group deployed $74.2B of net new capital in Q1 2026, opening 1,344 new positions and adding to 4,798 existing holdings. Its largest new stake was Sunbelt Rentals Holdings: 1,909,539 shares worth $124M.
By sector, the portfolio is most concentrated in Miscellaneous at 39% of assets, up from 38% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was UBS Group, an estimated $1.44B trimmed.
- UBS Group's largest Q1 2026 buy was Sunbelt Rentals Holdings: 1,909,539 shares worth $124M.
- UBS Group added most to iShares Core MSCI EAFE ETF in Q1 2026, an estimated $4.47B increase.
- UBS Group's biggest Q1 2026 reduction was UBS Group, cutting an estimated $1.44B.
- UBS Group fully exited CyberArk in Q1 2026, selling an estimated $851M.
- UBS Group's ten largest holdings make up 13% of its $666B portfolio in Q1 2026.
- UBS Group opened 1,344 new positions and closed 1,383 in Q1 2026.
- UBS Group's portfolio value rose 8% quarter-over-quarter to $666B.
Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.